APA (7th ed.) Citation

R, K., K, H., KE, L., L, D., KJ, C., MY, T., . . . BEK, K. (2017). The Relationship of Serum Soluble Receptor for Advanced Glycation End Products (sRAGE) and Carboxymethyl Lysine (CML) to the Incidence of Diabetic Nephropathy in Persons With Type 1 Diabetes. Diabetes care, 40(9), e117. https://doi.org/10.2337/dc17-0421

Chicago Style (17th ed.) Citation

R, Klein, Horak K, Lee KE, Danforth L, Cruickshanks KJ, Tsai MY, Gangnon RE, and Klein BEK. "The Relationship of Serum Soluble Receptor for Advanced Glycation End Products (sRAGE) and Carboxymethyl Lysine (CML) to the Incidence of Diabetic Nephropathy in Persons With Type 1 Diabetes." Diabetes Care 40, no. 9 (2017): e117. https://doi.org/10.2337/dc17-0421.

MLA (9th ed.) Citation

R, Klein, et al. "The Relationship of Serum Soluble Receptor for Advanced Glycation End Products (sRAGE) and Carboxymethyl Lysine (CML) to the Incidence of Diabetic Nephropathy in Persons With Type 1 Diabetes." Diabetes Care, vol. 40, no. 9, 2017, p. e117, https://doi.org/10.2337/dc17-0421.